Jul 27, 2017

EMERGO SUMMARY OF KEY POINTS:

  • The Indian CDSCO has published draft Essential Principles for medical device and IVD safety and performance.
  • Indian regulators are seeking industry comment through August 2017 on the proposed Essential Principles.
  • The draft Essential Principles are part of India’s new Medical Device Rules, 2017 slated for early 2018 implementation.

India CDSCO draft Essential Principles for medical devices and IVDsThe Central Drugs Standard Control Organization (CDSCO), India’s medical device market regulator, is seeking input from industry on draft essential safety and performance principles included in new regulations launching in 2018.

Stakeholders have three weeks to comment on the CDSCO’s draft Essential Principles for Safety and Performance of Medical Devices, which make up part of India’s new Medical Devices Rules, 2017. The document includes seven high-level requirements applying to all medical devices and IVD products registered for sale in India.

Seven CDSCO Essential Principles

The CDSCO’s seven draft Essential Principles that would be applicable to all devices under the Medical Device Rules, 2017 include:

  • A device’s manufacture and design will ensure that it performs as intended without compromising patient or user safety.
  • Device design and manufacturing solutions should conform to state-of-the-art safety and risk reduction principles.
  • A device’s design, production and packaging should be suitable to its intended purpose under normal conditions of use.
  • Safety and performance of a device should not be impacted in terms of compromised patient or user safety due to stresses of normal use.
  • Transport and storage conditions should not adversely impact a device’s characteristics or performance.
  • A manufacturer should minimize all “known and foreseeable risks, and any undesirable effects” to optimize benefits of using a device under normal conditions.
  • A device requires clinical evidence appropriate for its particular intended use and classification to show compliance with essential principles.

Along with the seven major principles for medical devices and IVDs listed above, the draft CDSCO document also addresses issues including chemical, physical and biological properties; infection and contamination risk mitigation; combination products; and medical devices containing biological materials.

Furthermore, the CDSCO has proposed requiring registered manufacturers to maintain documentation demonstrating conformance of their devices to the Essential Principles.

Related Indian medical device market resources:

Author

  • Stewart Eisenhart

Related

India’s CDSCO Issues New List of Medical Devices and their Classifications

EMERGO SUMMARY OF KEY POINTS:

  • Draft CDSCO list clarifies medical device and IVD types notified for Indian market registration
  • More types of IVD products would fall under Medical Device Rules 2017 notification requirements
  • Formal inclusion of devices requiring registration but not previously added to notification list
Read more

India Authorized Agent Role Changes under New Medical Device Rules

EMERGO SUMMARY OF KEY POINTS:

  • India’s new Medical Device Rules include expanded responsibilities for India Authorized Agent in-country representatives.
  • India Authorized Agents will have added importation responsibilities, and CDSCO will allow multiple Agents for imported devices.
  • Agent role changes will go into effect assuming that Indian regulators are able to meet their own early 2018 implementation timeframe.
Read more

India Update: New Medical Device Rules Will Apply Only to Products Currently Regulated by CDSCO

EMERGO SUMMARY OF KEY POINTS:

  • New Indian Medical Device Rules will cover only those device types that already fall under CDSCO oversight.
  • Existing Indian registrations will remain valid until 2020, according to informal discussions with the CDSCO.

Read more

Have questions on what Emergo can do for you?

CONTACT US